Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 442 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Whole-genome landscape of pancreatic neuroendocrine tumoursScarpa, A.; Chang, D.; Nones, K.; Corbo, V.; Patch, A.; Bailey, P.; Lawlor, R.; Johns, A.; Miller, D.; Mafficini, A.; Rusev, B.; Scardoni, M.; Antonello, D.; Barbi, S.; Sikora, K.; Cingarlini, S.; Vicentini, C.; McKay, S.; Quinn, M.; Bruxner, T.; et al.
2016Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesisWestphalen, C.; Takemoto, Y.; Tanaka, T.; Macchini, M.; Jiang, Z.; Renz, B.; Chen, X.; Ormanns, S.; Nagar, K.; Tailor, Y.; May, R.; Cho, Y.; Asfaha, S.; Worthley, D.; Hayakawa, Y.; Urbanska, A.; Quante, M.; Reichert, M.; Broyde, J.; Subramaniam, P.; et al.
2016Genomic analyses identify molecular subtypes of pancreatic cancerBailey, P.; Chang, D.; Nones, K.; Johns, A.; Patch, A.; Gingras, M.; Miller, D.; Christ, A.; Bruxner, T.; Quinn, M.; Nourse, C.; Murtaugh, L.; Harliwong, I.; Idrisoglu, S.; Manning, S.; Nourbakhsh, E.; Wani, S.; Fink, L.; Holmes, O.; Chin, V.; et al.
2017Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisHerold, T.; Schneider, S.; Metzeler, K.; Neumann, M.; Hartmann, L.; Roberts, K.; Konstandin, N.; Greif, P.; Braeundl, K.; Ksienzyk, B.; Huk, N.; Schneider, I.; Zellmeier, E.; Jurinovic, V.; Mansmann, U.; Hiddemann, W.; Mullighan, C.; Bohlander, S.; Spiekermann, K.; Hoelzer, D.; et al.
2015Whole genomes redefine the mutational landscape of pancreatic cancerWaddell, N.; Pajic, M.; Patch, A.; Chang, D.; Kassahn, K.; Bailey, P.; Johns, A.; Miller, D.; Nones, K.; Quek, K.; Quinn, M.; Robertson, A.; Fadlullah, M.; Bruxner, T.; Christ, A.; Harliwong, I.; Idrisoglu, S.; Manning, S.; Nourse, C.; Nourbakhsh, E.; et al.
2015CONSERTING: integrating copy-number analysis with structural-variation detectionChen, X.; Gupta, P.; Wang, J.; Nakitandwe, J.; Roberts, K.; Dalton, J.D.; Parker, M.; Patel, S.; Holmfeldt, L.; Payne, D.; Easton, J.; Ma, J.; Rusch, M.; Wu, G.; Patel, A.; Baker, S.J.; Dyer, M.A.; Shurtleff, S.; Espy, S.; Pounds, S.; et al.
2017Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cellsOoi, J.; Petersen, J.; Tan, Y.; Huynh, M.; Willett, Z.; Ramarathinam, S.; Eggenhuizen, P.; Loh, K.; Watson, K.; Gan, P.; Alikhan, M.; Dudek, N.; Handel, A.; Hudson, B.; Fugger, L.; Power, D.; Holt, S.; Coates, P.; Gregersen, J.; Purcell, A.; et al.
2016GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancerChen, M.; O'Mara, T.; Thompson, D.; Painter, J.; Attia, J.; Black, A.; Brinton, L.; Chanock, S.; Chen, C.; Cheng, T.; Cook, L.; Crous-Bou, M.; Doherty, J.; Friedenreich, C.; Garcia-Closas, M.; Gaudet, M.; Gorman, M.; Haiman, C.; Hankinson, S.; Hartge, P.; et al.
2017A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphomaCzuczman, M.; Trněný, M.; Davies, A.; Rule, S.; Linton, K.; Wagner-Johnston, N.; Gascoyne, R.; Slack, G.; Brousset, P.; Eberhard, D.; Hernandez-Ilizaliturri, F.; Salles, G.; Witzig, T.; Zinzani, P.; Wright, G.; Staudt, L.; Yang, Y.; Williams, P.; Lih, C.; Russo, J.; et al.
2017Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysisDale, C.; Fatemifar, G.; Palmer, T.; White, J.; Prieto-Merino, D.; Zabaneh, D.; Engmann, J.; Shah, T.; Wong, A.; Warren, H.; McLachlan, S.; Trompet, S.; Moldovan, M.; Morris, R.; Sofat, R.; Kumari, M.; Hyppönen, E.; Jefferis, B.; Gaunt, T.; Ben-Shlomo, Y.; et al.